Literature DB >> 24614546

Bilateral lacrimal drainage obstruction and its association with secondary causes.

Rachel K Sobel1, Keith D Carter, Richard C Allen.   

Abstract

PURPOSE: Etiologies of lacrimal obstruction requiring a dacryocystorhinostomy (DCR) have been reviewed previously but most commonly are thought to result from "primary acquired" nasolacrimal duct obstruction, a process of chronic inflammation in a narrowed duct. The authors have observed that secondary causes are frequently associated with bilateral lacrimal outflow disease. The purpose of this study is to investigate this relationship to help the clinician prioritize which patients to evaluate for secondary causes.
METHODS: This is a retrospective case-controlled review of patients who underwent bilateral DCR from 1986 to 2012 at this institution. They are compared with an age and gender-matched control group who underwent unilateral DCR. Statistical analysis was undertaken using the Pearson chi-square test for p value, except for age, which used the Wilcoxon rank sum test. Logistic regression was used for comparing prevalence of secondary issues in bilateral disease versus unilateral disease, with age as covariate.
RESULTS: Two hundred thirty-five patients underwent bilateral (91) or unilateral DCR (144). Twice as many patients undergoing bilateral DCR had an underlying secondary cause compared with the patients undergoing unilateral DCR. (38%, 19%, p= 0.001, odds ratio 2.59). In patients <50, the odds ratio of a secondary cause in bilateral disease would be 5.34 compared with patients older than 80. (p = 0.0002) Patients in the bilateral DCR group underwent revisions at more than twice the rate as patients in the unilateral DCR group (26%, 12%, p = 0.007).
CONCLUSIONS: Ophthalmologists should have a high index of suspicion for secondary conditions underlying bilateral lacrimal outflow obstruction, especially in patients <50. These patients should undergo laboratory workup and intraoperative biopsy. They should also be counseled regarding a higher failure rate.

Entities:  

Mesh:

Year:  2014        PMID: 24614546     DOI: 10.1097/IOP.0000000000000034

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  6 in total

1.  'Preoperative imaging should be performed for all cases of acquired nasolacrimal duct obstruction'-No.

Authors:  J C P Roos; D G Ezra; G E Rose
Journal:  Eye (Lond)       Date:  2016-11-04       Impact factor: 3.775

2.  Revision Surgery After Dacryocystorhinostomy in a National Cohort.

Authors:  Kian Eftekhari; Elliot D Kozin; Brian L VanderBeek
Journal:  JAMA Ophthalmol       Date:  2018-01-01       Impact factor: 7.389

Review 3.  The role of surgery in antineutrophil cytoplasmic antibody-associated vasculitides affecting the nose and sinuses: A systematic review.

Authors:  Alfonso Luca Pendolino; Samit Unadkat; Henry Zhang; Monica Pendolino; Gerolamo Bianchi; Premjit S Randhawa; Peter J Andrews
Journal:  SAGE Open Med       Date:  2020-07-01

4.  The predictive value of nasolacrimal sac biopsy in endoscopic dacryocystorhinostomy.

Authors:  Ibrahim Eldsoky; Wael Fawzy Ismaiel; Abdulkarim Hasan; Mohamed Hussein Abdelazim; Ahmed Abd Alrahman Ibrahim; Mahmoud Elsaid Alsobky; Ahmed Rabie Mohammed
Journal:  Ann Med Surg (Lond)       Date:  2021-04-16

5.  Nine-Month Follow-up Results of Treatment for Nasolacrimal Duct Obstruction by Probing with Adjunctive Mitomycin C in Adults: A Prospective Randomized Placebo-Controlled Trial.

Authors:  Nader Dehghani; Mohamad Reza Fouladivanda; Mohamed Amin Ghobadifar; Gelayol Safshekan-Esfahani; Armin Akbarzadeh
Journal:  Chonnam Med J       Date:  2015-04-14

6.  Lacrimal Sac Mucoepidermoid Carcinoma with Metastases to the Cavernous Sinus Following Dacryocystorhinostomy Treated with Stereotactic Radiotherapy.

Authors:  Jonathan C P Roos; Bijan Beigi
Journal:  Case Rep Ophthalmol       Date:  2016-05-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.